AMBIO Trademark

Trademark Overview

On Wednesday, April 7, 2021, a trademark application was filed for AMBIO with the United States Patent and Trademark Office. The USPTO has given the AMBIO trademark a serial number of 90629077. The federal status of this trademark filing is REGISTERED as of Tuesday, October 18, 2022. This trademark is owned by Ambio Pharmaceuticals. The AMBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Pharmaceutical drug development services
ambio

General Information

Serial Number90629077
Word MarkAMBIO
Filing DateWednesday, April 7, 2021
Status700 - REGISTERED
Status DateTuesday, October 18, 2022
Registration Number6875075
Registration DateTuesday, October 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesBiochemical research and development; Pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code042
First Use Anywhere DateMonday, October 31, 2011
First Use In Commerce DateMonday, October 31, 2011

Trademark Owner History

Party NameAmbio Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842
Party NameAmbio Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842
Party NameAmbio Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeech Island, SC 29842

Trademark Events

Event DateEvent Description
Wednesday, May 24, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 18, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 18, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Monday, July 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 30, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 30, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, November 30, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 30, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, November 30, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 23, 2021ASSIGNED TO EXAMINER
Wednesday, July 21, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, July 20, 2021ASSIGNED TO LIE
Tuesday, June 29, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, April 10, 2021NEW APPLICATION ENTERED

Related Keywords

ambio development services drug pharmaceutical biochemical research